{
    "nct_id": "NCT06387303",
    "official_title": "Pain Control and Quality of Recovery After Intravenous Methadone Versus Intrathecal Morphine in Major Abdominal Surgery",
    "inclusion_criteria": "* Adult patients with an American Society of Anesthesiologists (ASA) physiological status I-III\n* Undergoing laparotomy with midline incision\n* Body mass index (BMI) between 18.5 and 45\n* Ability to understand and read English\n* Willingness and ability to comply with scheduled visits and study procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Not able or unwilling to sign consent\n* Patients undergoing ambulatory surgery or anticipated to be discharged sooner than 24 hours after surgery\n* Patients with chronic pain, requiring daily opioid use at the time of surgery, MME >60 as the FDA defines opioid tolerant as 60 MME, long-acting forms of opioids such as fentanyl patch, oxycontin.\n* Pregnant Women\n* Patients requiring emergent surgery\n* Contraindications to neuraxial anesthesia including:\n\n  * Coagulopathy\n  * localized infection at the site of injection\n  * pre-existing spinal pathology, specifically defined as active radiculopathy, severe central canal stenosis in the lumbar region, or an acute fracture in the lumbar region\n* length of the QT interval (QTc) >450 on the most recent preoperative electrocardiogram (EKG)\n* Prior spinal fusion\n* Active or Prior Substance Use Disorder, undergoing active treatment with Medication of Opioid Use Disorder including methadone (once daily dosing), Buprenorphine (any formulation) and Naltrexone",
    "miscellaneous_criteria": ""
}